ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Exchange of Emerging Technology Ideas Draws a Crowd in Cambridge

By: NewsUSA

(NewsUSA) - Advances in technology, particularly in the areas of artificial intelligence (AI) are reshaping the geopolitical landscape. At the Ash Carter Exchange in Cambridge, Massachusetts, nearly 30 distinguished speakers discussed how emerging technologies are pushing the scientific frontier, transforming national security, and necessitating new partnerships between academic institutions, government agencies, and the private sector.

The event was hosted by the Special Competitive Studies Project (SCSP), a nonprofit and nonpartisan initiative with a goal of making recommendations to strengthen America's long-term competitiveness in AI.

The speakers stressed that achieving technological leadership requires not only investment in AI, biotechnology, and robotics, but also a unified effort across government, academia, and private industry to accelerate progress and transform traditional approaches.

Some key themes from the event included:

Academic Evolution. Dr. Joseph E. Aoun, President of Northeastern University, emphasized the need to integrate AI as a fourth dimension of education alongside understanding the physical world, life, and social interactions. He also emphasized the need to shift from traditional education to lifetime learning, and the importance of producing more graduates in STEM fields that would support national security efforts.

Emerging Technology Extension. Anne Neuberger, the Deputy Assistant to the President and Deputy National Security Advisor for Cyber and Emerging Technologies discussed the evolving role of cyber capabilities and emerging technologies in protecting national security. She emphasized the potential of AI to enhance both offensive operations and defensive capabilities, such as identifying vulnerabilities and detecting anomalies. However, she warned of the risks of AI models trained on non-assured code, and emphasized the challenge of deterrence in cyberspace, especially with regard to ransomware threats.

Biotechnology and Robotics Revolution. Dr. Noubar Afeyan, founder and CEO of Flagship Pioneering and co-Founder of Moderna, highlighted the transformative role of AI in biotechnology, notably in generating protein sequences and antibodies to treat disease. The use of molecular markers for early disease detection could reduce healthcare costs and improve outcomes, he said. Although public-private partnerships have been essential to advancing technology, as in the case of the rapid development of a COVID-19 vaccine, Dr. Afeyan emphasized the need to guard against potential misuse of AI in biotechnology. Dr. Marc Raibert, Founder and Executive Director of the AI Institute, also discussed the evolution of robotics over the past 50 years, and reflected some of the issues raised at the SCSP’s recent AI+ Robotics Summit.

Overall, the message of the Ash Carter Exchange was clear: now is the time to align resources, reform outdated systems, and commit to collaborative progress if the United States is to uphold its strategic, technological, and ideological edge in the world.

Visit scsp.ai for more information, and the SCSP YouTube channel to watch sessions from the Ash Carter Exchange.

Recent Quotes

View More
Symbol Price Change (%)
AMZN  254.00
+0.00 (0.00%)
AAPL  269.05
+0.00 (0.00%)
AMD  259.65
+0.00 (0.00%)
BAC  53.56
+0.00 (0.00%)
GOOG  284.12
+0.00 (0.00%)
META  637.71
+0.00 (0.00%)
MSFT  517.03
+0.00 (0.00%)
NVDA  206.88
+0.00 (0.00%)
ORCL  257.85
+0.00 (0.00%)
TSLA  468.80
+0.43 (0.09%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.